Jiong Xia

age ~49

from Fremont, CA

Jiong Xia Phones & Addresses

  • 43654 Bryant St, Fremont, CA 94539
  • 40656 Caliente Way, Fremont, CA 94539 • 5104401858
  • Tracy, CA
  • Brentwood, CA
  • Stanford, CA
  • Alameda, CA
  • Santa Clara, CA

Us Patents

  • Tissue Characterization Using Intracardiac Impedances With An Implantable Lead System

    view source
  • US Patent:
    8010196, Aug 30, 2011
  • Filed:
    Mar 12, 2007
  • Appl. No.:
    11/684671
  • Inventors:
    Louis Wong - Sunnyvale CA, US
    Cem Shaquer - San Jose CA, US
    Gene A. Bornzin - Simi Valley CA, US
    Euljoon Park - Valencia CA, US
    Andre Walker - Monte Sereno CA, US
    Dorin Panescu - San Jose CA, US
    Jiong Xia - Stanford CA, US
    Shahrooz Shahparnia - Campbell CA, US
  • Assignee:
    Pacesetter, Inc. - Sunnyvale CA
  • International Classification:
    A61N 1/18
  • US Classification:
    607 28, 607 2, 607 9, 607 17, 600547
  • Abstract:
    An implantable system acquires intracardiac impedance with an implantable lead system. In one implementation, the system generates frequency-rich, low energy, multi-phasic waveforms that provide a net-zero charge and a net-zero voltage. When applied to bodily tissues, current pulses or voltage pulses having the multi-phasic waveform provide increased specificity and sensitivity in probing tissue. The effects of the applied pulses are sensed as a corresponding waveform. The waveforms of the applied and sensed pulses can be integrated to obtain corresponding area values that represent the current and voltage across a spectrum of frequencies. These areas can be compared to obtain a reliable impedance value for the tissue. Frequency response, phase delay, and response to modulated pulse width can also be measured to determine a relative capacitance of the tissue, indicative of infarcted tissue, blood to tissue ratio, degree of edema, and other physiological parameters.
  • Tissue Characterization Using Intracardiac Impedances With An Implantable Lead System

    view source
  • US Patent:
    8065005, Nov 22, 2011
  • Filed:
    Mar 12, 2007
  • Appl. No.:
    11/684688
  • Inventors:
    Louis Wong - Sunnyvale CA, US
    Cem Shaquer - San Jose CA, US
    Gene A. Bornzin - Simi Valley CA, US
    Euljoon Park - Valencia CA, US
    Andre Walker - Monte Sereno CA, US
    Dorin Panescu - San Jose CA, US
    Jiong Xia - Stanford CA, US
    Shahrooz Shahparnia - Campbell CA, US
  • Assignee:
    Pacesetter, Inc. - Sunnyvale CA
  • International Classification:
    A61N 1/18
  • US Classification:
    607 28, 607 2, 607 9, 607 17, 600547
  • Abstract:
    An implantable system acquires intracardiac impedance with an implantable lead system. In one implementation, the system generates frequency-rich, low energy, multi-phasic waveforms that provide a net-zero charge and a net-zero voltage. When applied to bodily tissues, current pulses or voltage pulses having the multi-phasic waveform provide increased specificity and sensitivity in probing tissue. The effects of the applied pulses are sensed as a corresponding waveform. The waveforms of the applied and sensed pulses can be integrated to obtain corresponding area values that represent the current and voltage across a spectrum of frequencies. These areas can be compared to obtain a reliable impedance value for the tissue. Frequency response, phase delay, and response to modulated pulse width can also be measured to determine a relative capacitance of the tissue, indicative of infarcted tissue, blood to tissue ratio, degree of edema, and other physiological parameters.
  • Tissue Characterization Using Intracardiac Impedances With An Implantable Lead System

    view source
  • US Patent:
    8306623, Nov 6, 2012
  • Filed:
    May 31, 2011
  • Appl. No.:
    13/149507
  • Inventors:
    Louis Wong - Sunnyvale CA, US
    Cem Shaquer - San Jose CA, US
    Gene A. Bornzin - Simi Valley CA, US
    Euljoon Park - Valencia CA, US
    Andre Walker - Monte Sereno CA, US
    Dorin Panescu - San Jose CA, US
    Jiong Xia - Stanford CA, US
    Shahrooz Shahparnia - Campbell CA, US
  • Assignee:
    Pacesetter, Inc. - Sunnyvale CA
  • International Classification:
    A61N 1/18
  • US Classification:
    607 28, 607 2, 607 9, 607 17, 600547
  • Abstract:
    An implantable system acquires intracardiac impedance with an implantable lead system. In one implementation, the system generates frequency-rich, low energy, multi-phasic waveforms that provide a net-zero charge and a net-zero voltage. When applied to bodily tissues, current pulses or voltage pulses having the multi-phasic waveform provide increased specificity and sensitivity in probing tissue. The effects of the applied pulses are sensed as a corresponding waveform. The waveforms of the applied and sensed pulses can be integrated to obtain corresponding area values that represent the current and voltage across a spectrum of frequencies. These areas can be compared to obtain a reliable impedance value for the tissue. Frequency response, phase delay, and response to modulated pulse width can also be measured to determine a relative capacitance of the tissue, indicative of infarcted tissue, blood to tissue ratio, degree of edema, and other physiological parameters.
  • Tissue Characterization Using Intracardiac Impedances With An Implantable Lead System

    view source
  • US Patent:
    7925349, Apr 12, 2011
  • Filed:
    Mar 12, 2007
  • Appl. No.:
    11/684681
  • Inventors:
    Louis Wong - Sunnyvale CA, US
    Cem Shaquer - San Jose CA, US
    Gene A. Bornzin - Simi Valley CA, US
    Euljoon Park - Valencia CA, US
    Andre Walker - Monte Sereno CA, US
    Dorin Panescu - San Jose CA, US
    Jiong Xia - Stanford CA, US
  • Assignee:
    Pacesetter, Inc. - Sunnyvale CA
  • International Classification:
    A61N 1/37
  • US Classification:
    607 28, 600547
  • Abstract:
    An implantable system acquires intracardiac impedance with an implantable lead system. In one implementation, the system generates frequency-rich, low energy, multi-phasic waveforms that provide a net-zero charge and a net-zero voltage. When applied to bodily tissues, current pulses or voltage pulses having the multi-phasic waveform provide increased specificity and sensitivity in probing tissue. The effects of the applied pulses are sensed as a corresponding waveform. The waveforms of the applied and sensed pulses can be integrated to obtain corresponding area values that represent the current and voltage across a spectrum of frequencies. These areas can be compared to obtain a reliable impedance value for the tissue. Frequency response, phase delay, and response to modulated pulse width can also be measured to determine a relative capacitance of the tissue, indicative of infarcted tissue, blood to tissue ratio, degree of edema, and other physiological parameters.
  • Communication Terminal For Hot-Swap Controllers

    view source
  • US Patent:
    20210041930, Feb 11, 2021
  • Filed:
    Aug 9, 2019
  • Appl. No.:
    16/536914
  • Inventors:
    - Limerick, IE
    Jiong Xia - Fremont CA, US
  • International Classification:
    G06F 1/28
    G06F 1/26
    G06F 1/30
    G01R 31/40
  • Abstract:
    A hot-swap controller regulates the supply of power from an input node to a load coupled to an output node. The controller includes at least one limiting circuit configured to control a first switch connected between the input node and the load to limit an output current of the first switch for application to the load. A control logic circuit determines a state of the first switch and outputs a local state signal, and a communication circuit responsive to the local state signal establishes a voltage or current level corresponding to the local state at a communication circuit output. A communication terminal is also provided that is responsive to the communication output and that is adapted to connect to a second communication terminal of a second hot-swap controller to communicate the local state to the second hot-swap controller.

Get Report for Jiong Xia from Fremont, CA, age ~49
Control profile